In collaboration with 15 different institutes in Europe, Charité/BIH forms a consortium of excellent scientists specialised in next-generation sequencing with the goal to facilitate and also distribute their state-of-the-art methods to academic labs and industry, worldwide. EASI-Genomics is an European Union Horizon 2020 infrastructure project (RIA) with a total budget of 10 million € that assume to handle between 150 and 300 projects over a period of four years (started in 2019). In particular, Charité/BIH is involved in technology watch and the development of single cell technologies and imaging.
Further information can be found on the EASI-Genomics Webpage.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Service description goes here. Lorem ipsum dolor sit amet, in falli deterruisset pri, utroque ponderum pertinax an vis.
Charité CIO Martin Peuker is driving digitization in the healthcare sector with the Health Data Platform. The jury awards him 1st prize in the Public Sector category for his outstandig achievment.
We are pleased to present our recent achievements in building the Human Cell Atlas of the Pancreas on single-cell resolution. Due to its high autolytic activities, the pancreas is a very challenging
Professor Dominik Niopek, Department of Biology at the TU, has been awarded the "Life Sciences Bridge - Aventis Foundation Postdoctoral Award" research prize sponsored by the Aventis Foundation. The
We are pleased to announce our novel computational model for reducing off-target effects in CRISPR-Cas9 approaches: The manuscript Coupling Cas9 to artificial inhibitory domains enhances CRISPR-Cas9
The Hub for Innovations in Digital Health (HiDiH) brings together two independent sites of excellent research and development in Berlin and in Heidelberg. HIDIH’s major branch in Berlin is the Center for Digital Health at the Charité and the Berlin Institute of Health (BIH).
If we caught your attention, you are interested in our work and would like to get in touch with us, please contact us via info@hidih.org